RNAi Silencing in Mouse Models of Neurodegenerative Diseases

E-ISSN： 1875-5704|4|2|161-167

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.4, Iss.2, 2007-04, pp. : 161-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

By Orlacchio Antonio Bernardi Giorgio Orlacchio Aldo Martino Sabata

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 10, 2008-10 ,pp. : 1161-1174

Informa Healthcare

Access to resources Recommend Favorite

Oxidative Stress and Altered Mitochondrial Function in Neurodegenerative Diseases: Lessons From Mouse Models

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 4, 2010-08 ,pp. : 439-454

Bentham Science Publishers

Access to resources Recommend Favorite

Mouse Models of Autoimmune Diseases

Current Drug Discovery Technologies, Vol. 6, Iss. 4, 2009-12 ,pp. : 262-269

Bentham Science Publishers

Access to resources Recommend Favorite

The emerging utility of animal models of chronic neurodegenerative diseases

By Kahle P.J. Haass C.

Expert Opinion on Therapeutic Targets, Vol. 5, Iss. 1, 2001-02 ,pp. : 125-132

Informa Healthcare

Access to resources Recommend Favorite

Natural Animal Models of Neurodegenerative Protein Misfolding Diseases

Current Pharmaceutical Design, Vol. 18, Iss. 8, 2012-03 ,pp. : 1148-1158

Bentham Science Publishers

Access to resources Recommend Favorite